Jane Street
TXG icon

Jane Street’s 10x Genomics TXG Stock Holding History

Jane Street’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30,100
Closed -$352K – 12424
2025
Q3 		$352K Buy
+30,100
New +$392K ﹤0.01% 8604
2025
Q2 		– Sell
-14,200
Closed -$124K – 10935
2025
Q1 		$124K Buy
+14,200
New +$179K ﹤0.01% 8701
2023
Q4 		– Sell
-10,900
Closed -$450K – 9831
2023
Q3 		$450K Sell
10,900
-24,600
-69% -$1.28M ﹤0.01% 6456
2023
Q2 		$1.98M Sell
35,500
-6,800
-16% -$368K ﹤0.01% 4171
2023
Q1 		$2.36M Sell
42,300
-4,700
-10% -$219K ﹤0.01% 3532
2022
Q4 		$1.71M Buy
47,000
+4,600
+11% +$150K ﹤0.01% 4092
2022
Q3 		$1.21M Buy
42,400
+11,800
+39% +$450K ﹤0.01% 5081
2022
Q2 		$1.39M Buy
30,600
+18,900
+162% +$981K ﹤0.01% 4868
2022
Q1 		$890K Buy
11,700
+6,200
+113% +$542K ﹤0.01% 6366
2021
Q4 		$819K Sell
5,500
-600
-10% -$91.9K ﹤0.01% 6311
2021
Q3 		$888K Buy
6,100
+1,000
+20% +$172K ﹤0.01% 6156
2021
Q2 		$999K Sell
5,100
-73,900
-94% -$13.4M ﹤0.01% 5849
2021
Q1 		$14.3M Buy
+79,000
New +$13.6M 0.01% 1245

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's TXG Position: Q1 2026 in Review

Jane Street sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 24,155 shares — an estimated $483K sold.

Jane Street first reported a position in TXG in Q3 2019 and held it in 23 quarters. The position peaked at $14.7M in Q3 2020. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Jane Street reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 24,155 10x Genomics shares in Q1 2026, an estimated $483K.
  • Jane Street first reported a position in 10x Genomics in Q3 2019 and held it in 23 quarters.
  • Jane Street's 10x Genomics position peaked at $14.7M in Q3 2020.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.